- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Recombinant humanized anti-PD-1 monoclonal antibody for injection
Total 1075 results
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
Merck KGaA, Darmstadt, GermanyTerminated
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain NeoplasmUnited States
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Innate PharmaCompleted
-
Shanghai Zhongshan HospitalZhejiang Cancer Hospital; Sun Yat-sen University; Cancer Institute and Hospital... and other collaboratorsRecruitingEsophageal Squamous Cell Carcinoma Stage II | Esophageal Squamous Cell Carcinoma Stage IIIChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Agenus Inc.; Dutch Cancer SocietyNot yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Anwita BiosciencesShanghai Junshi Bioscience Co., Ltd.RecruitingLymphoma | Solid Tumor, Adult | Neoplasm Malignant | Neoplasm, ExperimentalTaiwan
-
Second Affiliated Hospital, School of Medicine,...RecruitingRectal NeoplasmsChina
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
Sinocelltech Ltd.Tianjin Medical University Cancer Institute and HospitalUnknownEsophageal Squamous Cell CarcinomaChina
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immune Checkpoint Inhibitors | Overall Survival | Anti-programmed Death-1 Antibody | Metastatic Cervical Carcinoma | Persistent Advanced Cervical Carcinoma | Objective Remission Rate | Progression-free Survival | Severe Adverse EventsChina
-
CNBG-Virogin Biotech (Shanghai) Ltd.Not yet recruitingPrimary Hepatocellular Carcinoma
-
Roswell Park Cancer InstituteGlaxoSmithKlineActive, not recruitingClear Cell Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
YM BioSciencesCompletedRecurrent Diffuse Pontine GliomasUnited States, Canada, Israel
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruitingHER2-positive Gastric or Gastroesophageal Junction AdenocarcinomaChina
-
Shanghai Fosun Pharmaceutical Industrial Development...Recruiting
-
Sinocelltech Ltd.Unknown
-
Shixiu WuRecruiting
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
National Cancer Institute (NCI)CompletedLocalized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedCervical Squamous Cell Carcinoma | Recurrent Cervical CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-Small Cell Lung CancerChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Shandong Cancer Hospital and InstituteRecruitingBreast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Squamous Cell Cancer of Head and NeckChina
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruiting
-
Genor Biopharma Co., Ltd.Unknown
-
Beijing 302 HospitalRecruitingTNBC - Triple-Negative Breast CancerChina
-
Sun Yat-sen UniversityRecruitingEndometrial CancerChina
-
Jinling Hospital, ChinaRecruitingRenal Cell Carcinoma | Radiotherapy | Immune Checkpoint InhibitorChina
-
Shanghai Henlius BiotechRecruitingLymphoma | Advanced Tumors | Metastatic TumorsChina
-
Sun Yat-sen UniversityUnknownColorectal Cancer Stage IIIChina
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
ITabMed Co., Ltd.Not yet recruitingRecurrent or Metastatic Solid Tumors
-
EVIVE BiotechnologyPeking University Cancer Hospital & InstituteUnknownRelapsed or Refractory B-cell Lymphoma
-
Beijing Friendship HospitalRecruiting
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Endometrial CarcinomaUnited States
-
Guangxi Medical UniversityUnknownHepatocellular Carcinoma
-
Zhejiang UniversityRecruiting
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedStage IV Non-small Cell Lung CancerChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
Beijing Friendship HospitalRecruiting
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital TuebingenNot yet recruitingNSCLCGermany, Netherlands